Infection-Associated Malignancies

Infection-associated malignancies are cancers caused, wholly or in part, by chronic infection with specific viruses, bacteria, or parasites. They are a major and disproportionately preventable share of the global cancer burden, because the responsible agents — human papillomavirus, Helicobacter pylori, hepatitis B and C viruses, and Epstein-Barr virus among them — can be targeted by vaccination, treatment, or eradication.

Definition

Infection-associated malignancies are cancers for which a chronic or persistent infection by a defined biological agent is an established cause, such that the infection contributes to the multistage process of carcinogenesis at the affected site.

Scope

The topic covers the principal oncogenic infectious agents and the cancers they cause, the mechanisms by which chronic infection drives malignancy, the epidemiology of infection-attributable cancer and its geographic concentration, and why these cancers are an especially tractable target for prevention. It is reference knowledge about causation and burden, not a guide to managing or treating infection in an individual.

Core questions

• Which infectious agents are established causes of human cancer, and which cancers do they cause?
• By what mechanisms does chronic infection lead to malignant transformation?
• What share of the global cancer burden is attributable to infection, and how is it distributed geographically?
• Why are infection-associated cancers considered particularly preventable?

Key concepts

• Oncogenic viruses (HPV, HBV, HCV, EBV)
• Helicobacter pylori and gastric cancer
• Chronic inflammation as a tumour driver
• Direct viral oncoprotein action
• Persistent infection and latency
• Population attributable fraction for infection
• Vaccination and eradication as prevention
• Geographic concentration of burden

Mechanisms

Infectious agents promote cancer through several overlapping routes. Some, such as high-risk human papillomavirus, encode oncoproteins that directly inactivate host tumour-suppressor pathways and drive proliferation; others act indirectly by causing chronic inflammation and repeated tissue injury, as Helicobacter pylori does in the stomach and hepatitis B and C viruses do in the liver, generating a microenvironment that favours the accumulation of mutations. Epstein-Barr virus establishes lifelong latency and contributes to several lymphoid and epithelial cancers. In each case persistent rather than transient infection is the key, because malignancy emerges from the long-term interplay of viral or bacterial factors, host immunity, and the multistage biology of carcinogenesis. Because the initiating cause is an identifiable, often controllable infection, removing or preventing it can interrupt the pathway to cancer.

Clinical relevance

Recognising that certain cancers are infection-driven explains why prevention can act on the cause — for example through vaccination against oncogenic viruses or treatment of chronic infection — and why the burden is concentrated where these infections are common. This entry describes causation, mechanism, and burden as reference knowledge; it does not provide individualized recommendations on antimicrobial treatment, vaccination eligibility, or cancer screening.

Epidemiology

A substantial share of cancers worldwide is attributable to infection, with global analyses estimating on the order of one in six cancers as infection-related, and Helicobacter pylori, human papillomavirus, and the hepatitis B and C viruses accounting for most of that burden. The burden is unevenly distributed, falling disproportionately on lower-income regions where the responsible infections are more prevalent, which makes infection-associated cancer a prominent target for global prevention.

History

The infectious causation of cancer was long suspected but established only through twentieth-century work tying specific agents to specific tumours: prospective study linked hepatitis B virus to hepatocellular carcinoma, case-control and mechanistic work connected Helicobacter pylori to gastric cancer, and the demonstration that high-risk human papillomavirus causes cervical cancer reframed that disease as infection-driven and vaccine-preventable. Successive global analyses by the International Agency for Research on Cancer and collaborators have since quantified the worldwide burden of infection-attributable cancer and tracked its distribution.

Key figures

• Catherine de Martel
• Julie Parsonnet
• R. Palmer Beasley
• Harald zur Hausen

Seminal works

• beasley-1981
• parsonnet-1991
• demartel-2020

Frequently asked questions

What fraction of cancers is caused by infection?

Global analyses estimate that roughly one in six cancers worldwide is attributable to infectious agents, chiefly Helicobacter pylori, human papillomavirus, and hepatitis B and C viruses, though the exact share varies by region.

Why are infection-associated cancers considered especially preventable?

Because their cause is an identifiable infection, the pathway to cancer can be interrupted by preventing or controlling that infection — for example through vaccination against oncogenic viruses or treatment of chronic infection — making these cancers a high-yield target for prevention.